Gerlie Gieser

615 total citations · 1 hit paper
4 papers, 463 citations indexed

About

Gerlie Gieser is a scholar working on Pediatrics, Perinatology and Child Health, Surgery and Genetics. According to data from OpenAlex, Gerlie Gieser has authored 4 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pediatrics, Perinatology and Child Health, 1 paper in Surgery and 1 paper in Genetics. Recurrent topics in Gerlie Gieser's work include Organ Transplantation Techniques and Outcomes (1 paper), Acute Myeloid Leukemia Research (1 paper) and Lung Cancer Research Studies (1 paper). Gerlie Gieser is often cited by papers focused on Organ Transplantation Techniques and Outcomes (1 paper), Acute Myeloid Leukemia Research (1 paper) and Lung Cancer Research Studies (1 paper). Gerlie Gieser collaborates with scholars based in United States. Gerlie Gieser's co-authors include Stacy S. Shord, Gideon M. Blumenthal, Richard Pazdur, Anamitro Banerjee, Kumar G. Janoria, Xin Gao, Kirsten B. Goldberg, David A. Bateman, Ann T. Farrell and Christopher M. Sheth and has published in prestigious journals such as PEDIATRICS, Clinical Cancer Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Gerlie Gieser

4 papers receiving 455 citations

Hit Papers

FDA Approval Summary: (Da... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerlie Gieser United States 4 152 114 100 90 82 4 463
Lauren Price United States 13 210 1.4× 148 1.3× 153 1.5× 127 1.4× 33 0.4× 22 582
Silvia Graziani Brazil 11 148 1.0× 113 1.0× 152 1.5× 49 0.5× 53 0.6× 19 558
James J. Beaudoin United States 13 106 0.7× 104 0.9× 170 1.7× 64 0.7× 79 1.0× 22 492
Joshua Prey United States 13 242 1.6× 142 1.2× 113 1.1× 132 1.5× 16 0.2× 22 550
Małgorzata Krawczyk Poland 13 128 0.8× 23 0.2× 110 1.1× 49 0.5× 39 0.5× 54 467
Zhenyu Zhang China 15 151 1.0× 46 0.4× 78 0.8× 39 0.4× 80 1.0× 39 524
EJ Estlin United Kingdom 12 137 0.9× 50 0.4× 82 0.8× 22 0.2× 95 1.2× 25 454
Ruben A.G. van Eerden Netherlands 11 78 0.5× 58 0.5× 107 1.1× 41 0.5× 20 0.2× 24 319
Franciska J. Koopman Netherlands 7 140 0.9× 204 1.8× 301 3.0× 70 0.8× 77 0.9× 9 537
Jan A. Lieverst Netherlands 11 114 0.8× 88 0.8× 177 1.8× 37 0.4× 122 1.5× 12 448

Countries citing papers authored by Gerlie Gieser

Since Specialization
Citations

This map shows the geographic impact of Gerlie Gieser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerlie Gieser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerlie Gieser more than expected).

Fields of papers citing papers by Gerlie Gieser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerlie Gieser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerlie Gieser. The network helps show where Gerlie Gieser may publish in the future.

Co-authorship network of co-authors of Gerlie Gieser

This figure shows the co-authorship network connecting the top 25 collaborators of Gerlie Gieser. A scholar is included among the top collaborators of Gerlie Gieser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerlie Gieser. Gerlie Gieser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Krauss, Aviva C., Xin Gao, Liang Li, et al.. (2018). FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia. Clinical Cancer Research. 25(9). 2685–2690. 252 indexed citations breakdown →
2.
Larkins, Erin, Gideon M. Blumenthal, Huanyu Chen, et al.. (2016). FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non–Small Cell Lung Cancer Following Crizotinib. Clinical Cancer Research. 22(21). 5171–5176. 88 indexed citations
3.
Gieser, Gerlie, et al.. (2011). FDA Workshop on Pharmacodynamic and Pharmacogenomic Biomarkers in Solid Organ Transplantation28 September 2010Silver Spring, MD. Clinical Pharmacology & Therapeutics. 90(2). 217–220. 9 indexed citations
4.
Rodriguez, William, Arzu Selen, Debbie Avant, et al.. (2008). Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned. PEDIATRICS. 121(3). 530–539. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026